Nexstim Plc (FRA:5NX)

Market Cap	77.44M -20.1%
Revenue (ttm)	11.69M +16.2%
Net Income	50.10K
EPS	0.01
Shares Out	n/a
PE Ratio	1,545.64
Forward PE	46.93
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	9.39
Previous Close	9.08
Day's Range	9.39 - 9.39
52-Week Range	7.94 - 16.20
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Nexstim

Nexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company offers non-invasive brain stimulation technology for navigated transcranial magnetic stimulation (nTMS), including Navigated Brain Stimulation (NBS) system 6 for presurgical mapping of the speech and motor cortices of the brain, for the treatment of major depression and chronic unilateral neuropathic pain, and post-operative rehabilitation of motor defici...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2000
• Employees: 44
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 5NX

Financial Performance

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 27, 2026

Data Sources Report a data error